Spotlight: Rythm raises $11M for sleep wearable

Silver Lake and GIC have acquired "substantial" equity stakes in The deals, which value the provider of online family history data at $2.6 billion, were secured in part on belief in the potential of Ancestry to grow its DNA testing business. "Ancestry's rapidly expanding consumer DNA testing service has powerful network effects and widespread consumer appeal," Silver Lake Managing Partner Mike Bingle said in a statement. Last year, Ancestry introduced AncestryHealth, a service that moved it further into the consumer genomics space occupied by 23andMe. Release

> PatientsLikeMe hired digital health expert Monique Levy for a newly created SVP position. News

> Rythm raised $11 million to develop its sleep monitoring wearable device. Piece


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

> The Washington Post looked into the impact of industry data-sharing initiatives. Article

> SAFE-BioPharma outlined its role in the TransCelerate Shared Investigator Platform. Release

> Principia Biopharma picked Guardant Health to monitor the response of patients to its FGFR inhibitor. More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.